☰

Amanpreet Kaur - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Goyal Y, Busch GT, Pillai M, Li J, Boe RH, Grody EI, Chelvanambi M, Dardani IP, Emert B, Bodkin N, Braun J, Fingerman D, Kaur A, Jain N, Ravindran PT, et al. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature. PMID 37468627 DOI: 10.1038/s41586-023-06342-8  0.731
2023 Fane ME, Ecker BL, Kaur A, Marino GE, Alicea GM, Douglass SM, Chhabra Y, Webster MR, Marshall A, Colling R, Espinosa O, Coupe N, Maroo N, Campo L, Middleton MR, et al. Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 29: 2012. PMID 37183634 DOI: 10.1158/1078-0432.CCR-23-0871  0.545
2022 Dardani I, Emert BL, Goyal Y, Jiang CL, Kaur A, Lee J, Rouhanifard SH, Alicea GM, Fane ME, Xiao M, Herlyn M, Weeraratna AT, Raj A. ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ. Nature Methods. PMID 36280724 DOI: 10.1038/s41592-022-01653-6  0.655
2020 Fane ME, Ecker BL, Kaur A, Marino GE, Alicea GM, Douglass SM, Chhabra Y, Webster MR, Marshall A, Colling R, Espinosa O, Coupe N, Maroo N, Campo L, Middleton MR, et al. sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33097493 DOI: 10.1158/1078-0432.CCR-20-0446  0.567
2020 Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE, Douglass SM, Kaur A, Ecker BL, Gnanapradeepan K, Ndoye A, Kugel C, Valiga A, Palmer J, Liu Q, et al. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Molecular Cell. 77: 681. PMID 32032511 DOI: 10.1016/J.Molcel.2020.01.005  0.591
2019 Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE, Douglass SM, Kaur A, Ecker BL, Gnanapradeepan K, Ndoye A, Kugel C, Valiga A, Palmer J, Liu Q, et al. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Molecular Cell. PMID 31836388 DOI: 10.1016/J.Molcel.2019.11.009  0.639
2019 Rupp C, Isomursu A, Aakula A, Erickson A, Li S, Kaur A, Shah P, Pokharel YR, Trottman L, Lammerding J, Rannikko A, Taimen P, Mirtti T, Paatero I, Ivaska J, et al. Abstract 3486: Combined inhibition of tumor suppressors PTEN and PP2A drives anoikis resistance and is associated with therapy relapse in prostate cancer Cancer Research. 79: 3486-3486. DOI: 10.1158/1538-7445.Am2019-3486  0.383
2018 Kaur A, Ecker BL, Douglass SM, Kugel CH, Webster MR, Almeida FV, Somasundaram R, Hayden J, Ban E, Ahmadzadeh H, Franco-Barraza J, Shah N, Mellis IA, Keeney F, Kossenkov A, et al. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Cancer Discovery. PMID 30279173 DOI: 10.1158/2159-8290.Cd-18-0193  0.686
2018 Ecker BL, Kaur A, Douglass SM, Webster MR, Almeida FV, Marino G, Sinnamon AJ, Neuwirth MG, Alicea GM, Ndoye A, Fane M, Xu X, Sim MS, Deutsch GB, Faries MB, et al. Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis. Cancer Discovery. PMID 30279172 DOI: 10.1158/2159-8290.Cd-18-0168  0.601
2018 Kugel CH, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, et al. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29898988 DOI: 10.1158/1078-0432.Ccr-18-1116  0.589
2018 Webster MR, Fane M, Kaur A, Alicea G, Ecker BL, Ndoye A, Kugel C, Basu S, Valiga A, Appleton JL, Murphy ME, Weeraratna A. Abstract 993: Wnt-er is coming: WNT5A promotes a slow cycling phenotype via p53 in conditions of stress Tumor Biology. DOI: 10.1158/1538-7445.Am2018-993  0.525
2017 Ndoye A, Budina-Kolomets A, Kugel CH, Webster MR, Kaur A, Behera R, Rebecca VW, Li L, Brafford PA, Liu Q, Vashisht Gopal YN, Davies MA, Mills GB, Xu X, Wu H, et al. ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma. Cancer Research. PMID 28887323 DOI: 10.1158/0008-5472.Can-17-0907  0.613
2017 Behera R, Kaur A, Webster MR, Kim S, Ndoye A, Kugel CH, Alicea GM, Wang JX, Ghosh K, Cheng PF, Lisanti S, Marchbank K, Dang V, Levesque MP, Dummer R, et al. Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28232477 DOI: 10.1158/1078-0432.Ccr-17-0201  0.663
2017 Webster MR, Kaur A, Ndoye A, Kugel C, Basu S, Valiga A, Appleton J, Wang Y, Murphy M, Weeraratna AT. Abstract 4913: Invasive melanoma cells commandeer p53 activity to promote the survival of a therapy resistant subpopulation Cancer Research. 77: 4913-4913. DOI: 10.1158/1538-7445.Am2017-4913  0.429
2016 Kaur A, Westermarck J. Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1. Biochemical Society Transactions. 44: 1683-1693. PMID 27913678 DOI: 10.1042/Bst20160161  0.332
2016 Kaur A, Webster MR, Weeraratna AT. In the Wnt-er of life: Wnt signalling in melanoma and ageing. British Journal of Cancer. PMID 27764844 DOI: 10.1038/Bjc.2016.332  0.614
2016 Kaur A, Denisova O, Qiao X, Jumppanen M, Peuhu E, Ahmed SU, Raheem O, Haapasalo HK, Eriksson J, Chalmers AJ, Laakkonen PM, Westermarck J. PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells. Cancer Research. PMID 27671680 DOI: 10.1158/0008-5472.Can-16-1134  0.357
2016 Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH, Dang VM, Appleton J, O'Connell MP, Cheng P, Valiga AA, Morissette R, McDonnell NB, Ferrucci L, Kossenkov AV, et al. Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. PMID 27383789 DOI: 10.1038/Nature18939  0.583
2016 Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH, Dang VM, Appleton J, O'Connell MP, Cheng P, Valiga AA, Morissette R, McDonnell NB, Ferrucci L, Kossenkov AV, et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. PMID 27042933 DOI: 10.1038/Nature17392  0.67
2015 Kaur A, Elzagheid A, Birkman EM, Avoranta T, Kytölä V, Korkeila E, Syrjänen K, Westermarck J, Sundström J. Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer. Cancer Medicine. PMID 26377365 DOI: 10.1002/Cam4.541  0.321
2015 Webster MR, Xu M, Kinzler KA, Kaur A, Appleton J, O'Connell MP, Marchbank K, Valiga A, Dang VM, Perego M, Zhang G, Slipicevic A, Keeney F, Lehrmann E, Wood W, et al. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell & Melanoma Research. 28: 184-95. PMID 25407936 DOI: 10.1111/Pcmr.12330  0.629
2015 Webster MR, Xu M, Kinzler K, Kaur A, Appleton J, O'Connell MP, Marchbank K, Valiga A, Dang V, Perego M, Zhang G, Slipicevic A, Keeney F, Lehrmann E, Wood W, et al. Abstract B27: Wnt5A-expressing melanoma cells show classical markers of senescence following radiation and therapeutic stress, but retain the ability to metastasize and proliferate at distant sites Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-B27  0.303
2015 Behera R, Marchbank K, Kaur A, Dang V, Webster M, O'Connell M, Xu X, Weeraratna A. Abstract A11: Crosstalk between klotho and wnt5A drives age-related melanoma progression Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A11  0.635
2015 Kaur A, Marchbank K, Dang V, O'Connell M, Webster M, Appleton J, Cheng P, Valiga A, Morissette R, McDonnell N, Ferrucci L, Kossenkov A, Meeth K, Bosenberg M, Tang H, et al. Abstract A04: Aging microenvironment modulates melanoma invasion and metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A04  0.652
2015 Kauko O, Imanishi S, Kaur A, Laajala D, Kulesskiy E, Jumppanen M, Corthals G, Aittokallio T, Wennerberg K, Westermarck J. Abstract 5328: Protein phosphatase 2A activity is a major determinant of therapy response in cancer cells Cancer Research. 75: 5328-5328. DOI: 10.1158/1538-7445.Am2015-5328  0.368
2015 Kaur A, O'Connell M, Webster M, Behera R, Dang V, Ndoye A, Weeraratna A. Abstract 5092: Midkine as a potential target for combating drug resistance and invasion in melanoma Cancer Research. 75: 5092-5092. DOI: 10.1158/1538-7445.Am2015-5092  0.645
2015 Webster MR, Basu S, Kaur A, Appleton J, Murphy ME, Weeraratna AT. Abstract 3775: p53 is differentially regulated in proliferative and invasive melanoma cells Cancer Research. 75: 3775-3775. DOI: 10.1158/1538-7445.Am2015-3775  0.327
2015 Ndoye A, Budina A, Webster M, Kaur A, Behera R, Murphy M, Weeraratna AT. Abstract 2906: Role of autophagy in Wnt5A-mediated melanoma invasion and metastasis Cancer Research. 75: 2906-2906. DOI: 10.1158/1538-7445.Am2015-2906  0.403
2015 Behera R, Kaur A, Marchbank K, Dang V, Webster M, Xu X, Weeraratna AT. Abstract 1556: Role of Klotho in age-related melanoma progression Cancer Research. 75: 1556-1556. DOI: 10.1158/1538-7445.Am2015-1556  0.431
2014 Sekulic A, Weeraratna AT, MacKeigan JL, Kaur A, O'Connell M, Goodall ML, Barrett M, Lenkiewitz E, Holley T, Zismann V, Gordon M, Bollag G, Zhang C, Trent JM. Abstract LB-213: Discovery and molecular modeling of a novel mutation in the vemurafenib binding site of BRAF associated with therapeutic resistance in a patient with metastatic melanoma Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-213  0.377
2013 O'Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, Li L, Herlyn M, Villanueva J, Liu Q, Yin X, Widura S, Nelson J, Ruiz N, Camilli TC, et al. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discovery. 3: 1378-93. PMID 24104062 DOI: 10.1158/2159-8290.Cd-13-0005  0.644
2013 Westermarck J, Kaur A. Abstract A97: PPME1 is a novel target for synthetic lethal therapy in human gliomas. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A97  0.387
2012 Kaur A, Cvrljevic A, Westermarck J. Abstract B36: Re-activation of protein phosphatase 2A as a multi-target strategy for combating chemotherapy resistance of common cancer types Clinical Cancer Research. 18. DOI: 10.1158/1078-0432.Mechres-B36  0.368
Show low-probability matches.